8.510

+0.030 (+0.35%)
Range 8.020 - 8.590   (7.11%)
Open 8.105
Previous Close 8.480
Buy Price 8.400
Buy Volume 12
Sell Price 8.450
Sell Volume 29
Volume 3,747,302
Value -
Remark
Measurement Type Value
EPS (USD) 0.92
Trailing EPS (USD) -0.737
NAV (USD) 0.619
Cash In Hand (USD) 0.369
Dividend -
Dividend Yield (%) -
PE 9.253
Trailing PE -
Price / NAV 13.739
Price / Cash In Hand 23.044
Issued & Paid-up Shares 141,497,000
Treasury Shares 793,000
Market Cap (M) 1,204.139
Par Value (USD) n.a.
Beta - 75 Days 1.509
R-Squared - 75 Days(%) 0.06
Beta - 500 Days 0.61
R-Squared - 500 Days(%) 1.27
ISIN Code -
Under CPF Investment Scheme (CPFIS) No
Index Components
Delayed prices. Updated at 23 Jan 2021 05:00.
Data powered by

Upcoming Events

* Stock event date based on US timezone.

Earnings

Release Date 04 Mar 2021
View All Events

About LEXICON PHARMACEUTICALS INC

Lexicon Pharmaceuticals, Inc. (Lexicon Pharmaceuticals) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. Lexicon Pharmaceuticals uses its gene knockout technologies and an integrated platform of medical technologies to study the physiological and behavioral functions of almost 5,000 genes in mice and assessed the utility of the proteins encoded by the corresponding human genes as drug targets. It has five drug programs in various stages of clinical development and has advanced small molecule compounds from a number of additional drug programs into various stages of preclinical development and research. Its drug program includes LX4211, LX1032, LX1033, LX2931 and LX7101.

Loading Chart...